{
    "relation": [
        [
            "Feature key",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei"
        ],
        [
            "Position(s)",
            "1 \u2013 212",
            "1 \u2013 189",
            "1 \u2013 189",
            "1 \u2013 189"
        ],
        [
            "Length",
            "212",
            "189",
            "189",
            "189"
        ],
        [
            "Description",
            "Missing in isoform 3. 2 Publications Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.2 \"Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.\" Jaeger D., Stockert E., Scanlan M.J., Guere A.O., Jaeger E., Knuth A., Old L.J., Chen Y.-T. Cancer Res. 59:6197-6204(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), TISSUE SPECIFICITY. Ref.5 \"p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1.\" Saito A., Furukawa T., Fukushige S., Koyama S., Hoshi M., Hayashi Y., Horii A. J. Hum. Genet. 45:177-181(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2 AND 3), VARIANT ARG-125.",
            "MSFVE\u2026WPWKQ \u2192 MLSPANGEQLHLVNYVEDYL DSIESLPFDLQRNVSLMREI DAKYQE in isoform 2. 5 Publications Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.1 \"Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.\" Garkavtsev I.A., Kazarov A.R., Gudkov A.V., Riabowol K. Nat. Genet. 14:415-420(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), VARIANT ARG-125. Ref.2 \"Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.\" Jaeger D., Stockert E., Scanlan M.J., Guere A.O., Jaeger E., Knuth A., Old L.J., Chen Y.-T. Cancer Res. 59:6197-6204(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), TISSUE SPECIFICITY. Ref.5 \"p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1.\" Saito A., Furukawa T., Fukushige S., Koyama S., Hoshi M., Hayashi Y., Horii A. J. Hum. Genet. 45:177-181(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2 AND 3), VARIANT ARG-125. Ref.7 \"DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.\" Nagashima M., Shiseki M., Miura K., Hagiwara K., Linke S.P., Pedeux R., Wang X.W., Yokota J., Riabowol K., Harris C.C. Proc. Natl. Acad. Sci. U.S.A. 98:9671-9676(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2). Ref.11 \"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).\" The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).",
            "MSFVE\u2026WPWKQ \u2192 ME in isoform 4. 2 Publications Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.2 \"Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.\" Jaeger D., Stockert E., Scanlan M.J., Guere A.O., Jaeger E., Knuth A., Old L.J., Chen Y.-T. Cancer Res. 59:6197-6204(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), TISSUE SPECIFICITY. Ref.8 \"Complete sequencing and characterization of 21,243 full-length human cDNAs.\" Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S. Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).",
            "MSFVE\u2026WPWKQ \u2192 MSFVECPYHSPAERLVAEAD EGGPSAITE in isoform 5. Curated"
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "VSP_009129",
            "VSP_009126",
            "VSP_009127",
            "VSP_009128"
        ],
        [
            "Actions",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST"
        ]
    ],
    "pageTitle": "ING1 - Inhibitor of growth protein 1 - Homo sapiens (Human)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/Q9UK53",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042989891.18/warc/CC-MAIN-20150728002309-00263-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 814075484,
    "recordOffset": 814020609,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Alternative sequence VAR_017422 NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2; 3 AND 5), VARIANTS HNSCC ARG-125; ASP-335; SER-358 AND SER-359. Cited for: Abstract] Europe PMC] [ PubMed] [ Cancer Res. 60:3143-3146(2000) [ Shimizu K. Nishizaki K., Nishioka S., Etani T., Hanafusa H., Fukushima K., Ouchida M., Gunduz M., \"Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.\" Ref.4 <p>Manually curated information for which there is published experimental evidence.</p> <p><a href=\"/manual/evidences#ECO:0000269\">More\u2026</a></p> Manual assertion based on experiment ini N \u2192 S in HNSCC. 1 Publication 1 359\u00a0\u2013\u00a0359 <p>Describes natural variant(s) of the protein sequence.</p><p><a href='../manual/variant' target='_top'>More...</a></p>Natural varianti VAR_017421 NUCLEOTIDE SEQUENCE [GENOMIC DNA]",
    "textAfterTable": "Sequence databases Select the link destinations: EMBL nucleotide sequence database<br/><a href='/database/22'>More..</a>EMBLi GenBank nucleotide sequence database<br/><a href='/database/28'>More..</a>GenBanki DNA Data Bank of Japan; a nucleotide sequence database<br/><a href='/database/14'>More..</a>DDBJi Links Updated AF181849 mRNA. Translation: AAF07920.1. AF181850 mRNA. Translation: AAF07921.1. AF001954 mRNA. Translation: AAB60879.1. Frameshift. AF044076 mRNA. Translation: AAC00501.1. AF149721 mRNA. Translation: AAF37421.1. AF149722 mRNA. Translation: AAF37422.1. AF149723 mRNA. Translation: AAF37423.1. AF167551, AF167550 Genomic DNA. Translation: AAG02578.1. AF167551, AF167549 Genomic DNA. Translation: AAG02579.1. Sequence problems. AB037387 Genomic DNA. Translation: BAB08101.1. AB037387 Genomic DNA. Translation:",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}